У нас вы можете посмотреть бесплатно This Dividend King has dropped 20%... time to buy? или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
20%+ pullback. 50+ years of dividend raises. 9%+ dividend growth. Is this Dividend King finally on sale? 🤑 Get Jason’s real-money buy alerts + full portfolio (Patreon): 👉 Join here: / jasonfieber 📝 Want to get ideas like this by email? Get our free Dividends & Income newsletter — and we’ll also send you a FREE copy of Jason’s Early Retirement Blueprint: 👉 Sign up here: https://lp.dividendsandincome.com/erb 👍 If you enjoyed this breakdown, hit Like and Subscribe for a new Undervalued Dividend Growth Stock every week. A Dividend King Trading at a Rare Discount The stock featured in today's video is a diversified healthcare giant whose products span the human lifespan — from infant nutrition to life-saving medical devices. After a 20%+ slide in the share price, valuation multiples have compressed, and the dividend yield is now meaningfully above its recent historical average. ✅ 54 consecutive years of dividend increases (Dividend King) ✅ ~9% long-term dividend growth ✅ Healthy payout ratio (~49%) ✅ Strong balance sheet (AA- credit rating) ✅ Potentially 15% undervalued based on blended fair value estimates So what’s the catch? In this video, Jason Fieber breaks down the company’s diversified business model, secular healthcare tailwinds, dividend safety, growth outlook (including recent acquisitions), key risks (litigation, regulation, product recalls), and what the recent pullback means for long-term dividend growth investors. What you’ll learn in this video: ✅Why this Dividend King’s yield is higher than usual ✅How consistent 10% EPS growth supports continued dividend growth ✅Balance sheet strength + credit quality ✅A dividend discount model valuation ✅Whether this healthcare blue chip truly looks “cheap” today ⚠️ Reminder: This is not financial advice. Always do your own research. #dividends #investing #stocks #dividendstocks #passiveincome #dividendgrowth #dividendking #healthcare #longterminvesting